Asterias Biotherapeutics, Inc. (Asterias)

Oncology Corporate Profile

HQ Location

6300 Dumbarton Circle
Fremont, CA 94555

Company Description

Asterias Biotherapeutics is a development stage biotechnology company focusing in regenerative medicine. They are developing therapeutics based on two different platform technologies: pluripotent stem cells and dendritic cell cancer immunotherapy. Near term, they are leveraging these platforms to develop treatments to address significant unmet medical needs in neurology and oncology. These mature programs are focused on de-risked indications and are supported by robust proof-of-concept pre-clinical and clinical data.

Website: http://asteriasbiotherapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AST-VAC1telomerase-based cancer vaccineAcute Myelogenous Leukemia (AML)II

View additional information on product candidates here »

Pipeline image

Source


http://asteriasbiotherapeutics.com

Recent News Headlines

There are no news items to display